Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a $10 ruler save newborns from brain damage?

NCT ID NCT06687746

Diagnosis Sponsor: George Washington University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a simple, low-cost plastic ruler called the Bili-ruler to screen newborns for jaundice. Over 4,000 infants were checked with the ruler, a standard device, and visual inspection. The goal was to see if the ruler can accurately identify dangerous jaundice, especially in places where expensive equipment is not available.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bili-ruler (a low-cost plastic icterometer device)
What this could lead to
If accurate, this cheap tool could help prevent brain damage and death from severe newborn jaundice in low-resource settings worldwide.
What could go wrong
The trial is completed but results are not yet widely confirmed; the ruler may be less accurate than standard devices, and its real-world impact depends on training and consistent use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

4,060 people

The number who actually took part.

Started

Oct 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All infants who are born to mothers in the catchment areas covered by PRISMA study sites

Ages

Up to 28 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All infants who are born to PRISMA enrolled mothers will be eligible for this study. Exclusion Criteria: * Presence of skin lesions, abnormalities, etc on the baby's nose, face, and ears, which could interfere with bilirubin measurement, as determined by research staff.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Jaundice, neonatal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Congenital, Hereditary, and Neonatal Diseases and Abnormalities hyperbilirubinemia Hyperbilirubinemia, Neonatal Jaundice Jaundice, Neonatal perinatal disease transient familial neonatal hyperbilirubinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Jaundice, neonatal Neonatal diseases and abnormalities Neonatal hyperbilirubinemia Screening Screening tool

Contacts and locations

Locations

  • Aga Khan University

    Karachi, Pakistan, Pakistan

  • Christian Medical College (CMC)

    Vellore, India, India

  • Kenya Medical Research Institute - Center for Global Health Research

    Kisumu, Kenya, Kenya

  • Society for Applied Studies (SAS)

    Hodal, India, India

  • University of North Carolina - Global Projects Zambia

    Lusaka, Zambia, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.